Endotoxin and the hyperdynamic circulation of portal vein—ligated rats
✍ Scribed by Rajeev Mehta; Jeanne Gottstein; W. Patrick Zeller; Robert Lichtenberg; Andres T. Blei
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 584 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Humoral factors may be responsible for the hyperdynamic circulation seen in portal hypertension. Endotoxin, a peripheral arteriolar vasodilator, has been proposed to mediate this hernodynamic picture. We examined the pathogenic role of endotoxin in portal vein-ligated rats, a prehepatic portal hypertensive model with a well-developed hyperdynamic circulation. To this end, we (a) administered oral neomycin, a poorly absorbable antibiotic, at doses of 50 and 100 mg/day for 7 days and found no evident splanchnic hernodynamic effects of a 2-log-fold reduction of cecal aerobic bacterial flora as assessed by the radioactive microsphere technique in portal vein-ligated rats studied in the postanesthesia awake state; (b) assayed endotoxin in arterial samples using a quantitative limulus assay and found no evidence of endotoxinemia in PVL rats; (c) induced a state of endotoxin tolerance by repeated daily intraperitoneal injections of lowdose endotoxin and found no amelioration of the hyperdynamic state in portal vein-ligated rats. Our results do not support the hypothesis that endotoxin playa a maor pathogenic role in the hyperdynamic circulation of this experimental model. (HEPATOLOGY 1w)0;12:1152-1156.)
A hyperdynamic circulation, characterized by peripheral arterial vasodilatation and a high cardiac output, is a feature of both acute ( 1 ) and chronic (2) liver disease. Its pathogenesis remains unclear. Earlier studies suggested a bypass effect of portal-systemic shunting (3) similar to the consequences of arteriovenous fistulas on the circulation. Recently (41, the onset of the hyperdynamic state has been dissociated from the development of portocollateral circulation in rats after partial portal vein ligation (PVL), a model of extensive portal-systemic shunting. Because blood from such animals may induce a decrease of splanchnic (5) and hindquarter (6) arteriolar resistance in normal rats,
📜 SIMILAR VOLUMES
In chronic portal-hypertensive rat models, such as portal vein constriction or cirrhosis, the portal blood flow that effectively perfuses the hepatocytes is substantially reduced because of anatomical or functional shunts. It is possible therefore that a feedback mechanism from the liver to the spla
On day 0, the day before the first gavage, and on patients. This has stimulated the search for alternative drugs day 7 of treatment, blood and 24-hour urine sampling were perin the treatment of portal hypertension. Recent data have formed to determine (Na / ), (K / ), (creatinine), and osmolality. H
Portal hypertension (PHT) is characterized by splanchnic hyperemia due to enhanced production of vasodilator substances. Enhanced vasodilation and increased splanchnic blood flow contribute to the elevated portal pressure characteristic of PHT. The aim of this study was to determine whether cyclooxy
The in¯uence of portal hypertension on the metabolism and pharmacokinetics of aspirin was evaluated after the administration of a single oral dose of acetylsalicylic acid (20 mg kg 71 ) in portal-vein-ligated (PVL) rats. Experiments were also performed in control (sham-operated rats) and in rats tha
Increased circulating insulin and glucagon levels are a common observation in patients with cirrhosis, as well as in portal hypertensive models. Hyperinsulinemia and hyperglucagonemia may be caused either by increased beta-and alpha-cell secretion or by defective hepatic clearance of these hormones.